- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Risk Chronic Myelomonocytic Leukemia in Japan
Total 83 results
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Japan
-
Boehringer IngelheimCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicJapan
-
PfizerCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeSpain, Canada, Austria, Czechia, France, Hungary, Italy, Japan, Mexico, Poland, United Kingdom
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicChina, Czechia, Japan, Saudi Arabia, Taiwan, Turkey, Germany, Spain, Netherlands, Italy, Singapore, Australia, Austria, France, United Kingdom, Korea, Republic of, Thailand, Israel, Belgium, Canada, Switzerland, Lithuania, Russian Federation and more
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicJapan
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic and Lymphoma, FollicularJapan
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicKorea, Republic of, Japan
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Kanto CML Study GroupUnknownMyelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Myelogenous LeukemiaJapan
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan
-
AbbVieRecruiting
-
AstraZenecaRecruitingPreviously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)Japan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Japan
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompletedChronic Myeloid LeukemiaJapan
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompleted
-
Shimousa Hematology Study GroupEpidemiological and Clinical Research Information NetworkUnknown
-
Novo Nordisk A/SSponsor: Corvidia Therapeutics Inc, a subsidiary of Novo Nordisk A/SCompletedInflammation | Chronic Kidney Disease | Cardiovascular RiskJapan
-
Astex Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited States, Spain, Korea, Republic of, France, Denmark, Canada, Germany, Italy, Czechia, United Kingdom, Poland, Japan, Sweden, Belgium
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
SymBio PharmaceuticalsCompletedChronic Lymphocytic LeukemiaJapan
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellJapan
-
Janssen Pharmaceutical K.K.Completed
-
PfizerCompletedLeukemia, Chronic MyelogenousJapan
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicJapan
-
PfizerCompletedChronic Myelogenous LeukemiaJapan
-
National Hospital Organization Minami Kyoto HospitalCompletedRehabilitation | Chronic Respiratory Failure | Exercise Endurance | Nasal High Flow TherapyJapan
-
National Hospital Organization Minami Kyoto HospitalRecruitingChronic Respiratory Failure | Exercise Capacity | High-flow Nasal Cannula | Optimal SpO2 ValueJapan
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
Novartis PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaFinland, Spain, Korea, Republic of, Israel, Japan, Germany, Singapore
-
Ariad PharmaceuticalsCompletedChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)Japan
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive | Chronic Myelogenous Leukemia in Chronic PhaseJapan
-
AmgenCompletedHypercholesterolemia and High Risk for Cardiovascular EventsJapan
-
AstraZenecaActive, not recruitingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)Japan
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaJapan
-
AbbVieActive, not recruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Japan
-
Johnson & Johnson International (Singapore) Pte...CompletedHigh Risk Localized Prostate CancerJapan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaGermany, Australia, Netherlands, Spain, Korea, Republic of, France, Japan, Italy, Singapore, United States
-
Poitiers University HospitalUniversity Medical Center Groningen; Imperial College London; University of Liege and other collaboratorsRecruitingChronic Myeloid LeukemiaDenmark, China, Germany, Australia, Belgium, Brazil, Chile, Croatia, Czechia, France, Greece, Japan, Lebanon, Poland, Spain, Turkey, Austria, Belarus, Netherlands, Slovakia
-
GenmabAbbVieActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell LymphomaJapan
-
Novartis PharmaceuticalsCompletedPhiladelphia Positive (Ph+) Chronic Myelogenous LeukemiaUnited States, France, Korea, Republic of, Thailand, Italy, Netherlands, Turkey, Hungary, Russian Federation, Spain, United Kingdom, Japan, Malaysia
-
AmgenCompletedHyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular EventsJapan
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
Novartis PharmaceuticalsRecruitingLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myelogenous LeukemiaDenmark, Spain, France, Germany, Lebanon, Italy, Argentina, Czechia, Portugal, United Kingdom, Brazil, Mexico, Russian Federation, Taiwan, Austria, Canada, Korea, Republic of, Turkey, United States, Singapore, Japan, Bulgaria, Poland, Romani... and more
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaBelgium, Spain, Austria, Germany, Italy, France, Netherlands, Sweden, Japan, United States, Greece, United Kingdom, Bulgaria, Hungary, Argentina, Poland, Colombia, Ireland, Denmark